Key result
Antisense oligodeoxynucleotides to AGT mRNA and AT1 receptor mRNA significantly reduced systolic blood pressure by up to 41+/-10 mm Hg in rats with cold-induced hypertension.
Why the study?
Does antisense oligodeoxynucleotide inhibition of AGT or AT1 receptor mRNA reduce blood pressure in cold-induced hypertensive rats?
Does antisense oligodeoxynucleotide inhibition of AGT or AT1 receptor mRNA reduce blood pressure in cold-induced hypertensive rats?
Antisense oligodeoxynucleotides targeting the renin-angiotensin system effectively reduce blood pressure in a rat model of cold-induced hypertension, highlighting the role of both central and peripheral RAS in this model.
Answers are grounded in this paper and cite their sources.
Cold-induced hypertension in rats engages multi-compartment RAS; leaves open relevance to human environmental hypertension.
Rats exposed chronically to mild cold (5 degrees C/41 degrees F) develop hypertension and cardiac hypertrophy. This provides a unique model of hypertension that is environmentally induced. The blood renin-angiotensin system (RAS) has been shown to play a role in both initiating and maintaining the high blood pressure (BP) in cold-induced hypertension. The mechanism also appears to involve both the tissue and brain RAS because there is increased mRNA for angiotensinogen (AGT) and angiotensin type 1 (AT1) receptors in brain and peripheral tissues, an increased spontaneous drinking response, and an increased dipsogenic response to acute administration of angiotensin II (Ang II) in cold-treated rats. Antisense oligodeoxynucleotides (AS-ODN), targeted to the RAS, have been shown to reduce BP in spontaneously hypertensive rats. Therefore, we injected AS-ODN in rats with cold-induced hypertension to test whether antisense inhibition was effective in reducing this nongenetic nonsurgical hypertension. Sprague-Dawley rats were made hypertensive by cold exposure and injected intracerebroventricularly with AS-ODN to AGT mRNA (n=6) or AT1 receptor mRNA (n=6). Systolic BP was recorded by tail cuff 24 hours later for 2 or 7 days, respectively. Systolic BP decreased significantly in response to AGT-AS-ODN (40+/-6 mm Hg, P<0.01) within 1 day after injection and to AT1 receptor-AS-ODN (P<0.05) for 3 days after injection. The maximum decrease was 41+/-10 mm Hg. Systolic BP then gradually increased to the preinjection level. The spontaneous drinking response to cold treatment also decreased significantly (P<0.05) after AGT-AS-ODN or AT1 receptor-AS-ODN intracerebroventricular injection. Intracardiac injection of AT1-AS-ODN (n=6) reduced systolic BP by 36+/-8 mm Hg (P<0.05) and decreased AT1 receptor as measured by autoradiography in aorta, adrenal glands, and kidneys 24 hours after injection. These data show that AS-ODN reduces BP in cold-induced hypertension and that the hypertension involves both peripheral tissues and central RAS in addition to blood-borne RAS mechanisms.
No takes yet. Share an insight, caveat, or question.
Peng et al. (1998) studied Cold-induced hypertension (n=18). Antisense oligodeoxynucleotides (AS-ODN) to AGT mRNA or AT1 receptor mRNA vs. Preinjection baseline was evaluated on Systolic blood pressure (40+/-6 mm Hg decrease, p=<0.01). Antisense oligodeoxynucleotides to AGT mRNA and AT1 receptor mRNA significantly reduced systolic blood pressure by up to 41+/-10 mm Hg in rats with cold-induced hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: